Elos Medtech – Annual Report 2016 published

The Swedish version of Elos Medtech Annual Report 2016 was today published at our web site www.elosmedtech.com

The printed version will be distributed end of week 15 to shareholders who wish to receive corporate information in accordance with Euroclear. The report can also be ordered at info@elosmedtech.com

The English version of Elos Medtech Annual Report 2016 will be available at the web site www.elosmedtech.com in late April.

Göteborg, April 5, 2017

Elos Medtech AB (publ)

For further information, please contact: Jan Wahlström, CEO, +46 70 212 18 89, jan.wahlstrom@elosmedtech.com or Christian Bergaust CFO, +46 70 293 50 40, christian.bergaust@elosmedtech.com

For additional information about the Elos Medtech Group, visit www.elosmedtech.com 

This information is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on April 5, 2017, at 17:00 (CET).


About Us

Elos Medtech is one of Europe's leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental Implant Systems, Diagnostics, Medical Devices and Trauma & Spine. Elos Medtech employs more than 500 people worldwide and generates revenue that exceeds MSEK 550. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.